Document Detail

Intermittent heparin infusion in children with ischemic heart disease caused by Kawasaki disease.
MedLine Citation:
PMID:  18243369     Owner:  NLM     Status:  MEDLINE    
We determined change in serum hepatocyte growth factor (HGF), one of the most potent angiogenic factors, after intravenous infusion of heparin in children and reported successful improvement of cardiac ischemia after regular intravenous heparin infusion in an infant with ischemic heart disease (IHD) caused by Kawasaki disease (KD). Intravenous infusion of 50 units/kg of heparin significantly increased serum HGF from 0.8+/-0.6 to 8.4+/-3.4 at 5 min, 8.3+/-2.5 at 30 min, and 4.9+/-1.5 ng/ml at 60 min, respectively. Subsequently, a 16-month-old infant with IHD caused by KD had received regular intravenous infusion of heparin, 100 IU/kg twice a day for 1 month and once a week for subsequent 2 months. With this treatment, his perfusion defect on myocardial scintigraphy disappeared. In conclusion, regular heparin infusion alone can improve myocardial ischemia caused by KD, probably due to facilitated production of HGF.
Kenji Suda; Masahiko Mastumoto; Setsuko Miyanishi
Related Documents :
15448779 - Treating heparin-induced thrombocytopenia. the unconventional way!
10543929 - Activated partial thromboplastin time and clinical outcome after thrombin inhibition in...
18434719 - Less benefit from warfarin in diabetics after myocardial infarction?
19530369 - The role of low-molecular-weight heparins in the management of unstable angina and non-...
2278869 - French multicenter trial of anistreplase versus heparin in acute myocardial infarction.
18412079 - What anti-thrombotic therapy is best with primary pci for acute st elevation myocardial...
9725159 - Effects of left atrial dilatation on the endocardial atrial defibrillation threshold: a...
19050639 - Can the abdominal perimeter be used as an accurate estimation of intra-abdominal pressure?
19755919 - Postinfarct treatment with oxytocin improves cardiac function and remodeling via activa...
Publication Detail:
Type:  Comparative Study; Letter     Date:  2008-02-19
Journal Detail:
Title:  International journal of cardiology     Volume:  133     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-06     Completed Date:  2010-01-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  417-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Catheters, Indwelling
Child, Preschool
Heparin / administration & dosage*
Hepatocyte Growth Factor / blood
Infusions, Intravenous
Mucocutaneous Lymph Node Syndrome / blood,  complications*,  drug therapy*
Myocardial Ischemia / blood,  drug therapy*,  etiology*
Reg. No./Substance:
67256-21-7/Hepatocyte Growth Factor; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Responses of parathyroid hormone to vitamin D supplementation: A systematic review of clinical trial...
Next Document:  Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage hear...